Enlarged Board of Appeal fails to offer clear guidance in highly-anticipated “plausibility” opinion
The EBA has not laid out clear rules about when post-filed evidence can be used to demonstrate technical effect
The EBA has not laid out clear rules about when post-filed evidence can be used to demonstrate technical effect
The Munich Regional Court has clarified its stance on the hot topic in German patent litigation, ruling on the new defence in three parallel SEP cases, providing welcome clarity for future litigation strategies.
While the codification of remote hearings, a triple exchange of briefs and the simplification of procedures may present new challenges, these new reforms should ultimately bring about positive changes to the justice system by streamlining and modernising procedures.
Chief IP officers at large and small companies – especially life sciences – are closely watching the case which promises to settle debate about what comprises sufficient enablement under Section 112
15 March 2023
The Delhi High Court has had to raise natural justice principles with the Patent Office in multiple 2022 cases, a crucial reminder that parties must be provided with fair opportunities and rulings backed with reasonable explanations.
15 March 2023
Ethical and transparent partnerships can help resolve pressing issues all while furthering a company’s goals and interests
08 March 2023
In what can be seen as a relief for patent holders, the new disproportionality exception for the enforcement of patent injunctions has left the German district courts' strict approach to injunctions unchanged.
08 March 2023
Under the Greek Patent Law, European patent applicants can enjoy provisional protection against potential infringers, so long as they successfully carry out certain formalities and can justify that their request is sufficiently urgent.
08 March 2023
Potential initiatives to limit continuation practice are causing deep divides in the life sciences patent community – causing technology licensors and Big Tech to take sides
07 March 2023
Saturday Opinion: Disseminating covid diagnostics and therapeutics is critical, but attempting to do so via the TRIPS waiver extension is rife with unintended consequences
04 March 2023
The country’s highest court grappled with questions that are fundamental to the future of patent law
03 March 2023
Without significant reforms that restore the right to exclude, lower costs and clarify eligibility, SMEs will remain second class citizens and the big calls on FRAND and SEPs will be made in Europe
02 March 2023
The region is lagging behind its global peers in invention productivity but there are ways this gulf can be crossed
24 February 2023
Unlock unlimited access to all IAM content